Mesalamine Export Market Intelligence: India's 103 Suppliers Shipping to 51 Countries — TransData Nexus 2026

Q: Who are the top mesalamine exporters from India?

The top mesalamine exporters from India are: 1. ZYDUS LIFESCIENCES LIMITED — $1.0B (78.8% market share); 2. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $180.4M (13.7% market share); 3. CADILA HEALTHCARE LIMITED — $46.4M (3.5% market share); 4. ANNORA PHARMA PRIVATE LIMITED — $24.1M (1.8% market share); 5. CADILA HEALTHCARE LTD — $9.7M (0.7% market share). Together they account for 98.5% of India's total mesalamine export value.

Q: What is the total export value of mesalamine from India?

The total export value of mesalamine from India is $1.3B USD, recorded across 3,779 shipment transactions from 103 active exporters to 51 destination countries. The average shipment value is $349.1K.

Q: Which countries import mesalamine from India?

India exports mesalamine to 51 countries worldwide. The top importing countries are: UNITED STATES (98.6% share, $1.3B), RUSSIA (0.4% share, $5.3M), ALGERIA (0.3% share, $4.2M), AUSTRALIA (0.2% share, $2.3M), MEXICO (0.1% share, $1.4M). These five markets account for 99.6% of total export value.

Q: What is the HS code for mesalamine exports from India?

The primary HS code for mesalamine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of mesalamine exports from India?

The average unit price for mesalamine exports from India is $13.15 USD per unit, with prices ranging from $0.01 to $2657.70 depending on formulation, packaging, and order volume. The total market is valued at $1.3B across 3,779 shipments.

Q: Which ports handle mesalamine exports from India?

The primary ports for mesalamine exports from India are DELHI AIR CARGO ACC (INDEL4) (21.2% of shipments), SAHAR AIR (20.9% of shipments), DELHI AIR (13.1% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.0% of shipments), MUNDRA SEA (3.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of mesalamine?

India is one of the world's leading exporters of mesalamine due to its large base of 103 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports mesalamine to 51 countries, demonstrating 26% global market coverage.

Q: What certifications do Indian mesalamine exporters need?

Indian mesalamine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import mesalamine from India?

There are 214 registered buyers importing mesalamine from India, spread across 51 countries. The repeat buyer rate is 64.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top mesalamine supplier from India?

ZYDUS LIFESCIENCES LIMITED is the leading mesalamine exporter from India with a market share of 78.8% and total export value of $1.0B across 386 shipments. The top 5 suppliers together control 98.5% of total export value.

Suresh Sormare

Mesalamine

India Pharmaceutical Trade Intelligence

$1.3B103 Suppliers51 CountriesHS 30049099

ExportsIndia → UNITED STATES98.6%India → RUSSIA0.4%

ImportsUNITED STATES → India$1.0M ISRAEL → India$27.3K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Mesalamine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Mesalamine to the World

Between 2022 and 2026, India exported $1.3B worth of mesalamine across 3,779 verified shipments to 51 countries — covering 26% of world markets in the Gastrointestinal segment. The largest destination is UNITED STATES (98.6%). ZYDUS LIFESCIENCES LIMITED leads with a 78.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Mesalamine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Mesalamine export data snapshot — $1.3B · 103 exporters · 51 countriesTransData Nexus · Indian Customs Data

Top Mesalamine Exporters from India

103 active exporters · Ranked by export value

View all 103 →

Top Mesalamine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ZYDUS LIFESCIENCES LIMITED	$1.0B	386	6	78.8%
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED

Top Countries Importing Mesalamine from India

51 destination markets · Ranked by import value

All 51 countries →

Top Countries Importing Mesalamine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$1.3B	98.6%
2	RUSSIA	$5.3M	0.4%
3	ALGERIA	$4.2M	0.3%
4	AUSTRALIA	$2.3M	0.2%
5	MEXICO	$1.4M	0.1%
6	LITHUANIA	$1.2M	0.1%
7	BRAZIL	$1.1M	0.1%
8	MAURITIUS	$457.5K	0.0%
9	UNITED KINGDOM	$407.8K	0.0%
10	BELARUS	$339.1K	0.0%

UNITED STATES is India's largest mesalamine export destination, absorbing 98.6% of total exports worth $1.3B. The top 5 importing countries — UNITED STATES, RUSSIA, ALGERIA, AUSTRALIA, MEXICO — together account for 99.6% of India's total mesalamine export value. The remaining 46 destination countries collectively receive the other 0.4%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Mesalamine to India?

6 origin countries · Total import value: $1.1M

India imports mesalamine from 6 countries with a combined import value of $1.1M. The largest supplier is UNITED STATES ($1.0M, 248 shipments), followed by ISRAEL and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Mesalamine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$1.0M	248	95.8%
2	ISRAEL	$27.3K	7	2.6%
3	CANADA	$12.6K	20	1.2%
4	NETHERLANDS	$2.7K	2	0.3%
5	CHINA	$1.8K	26	0.2%
6	TAIWAN	$153	1	0.0%

UNITED STATES is the largest supplier of mesalamine to India, accounting for 95.8% of total import value. The top 5 origin countries — UNITED STATES, ISRAEL, CANADA, NETHERLANDS, CHINA — together supply 100.0% of India's mesalamine imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Mesalamine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, mesalamine is approved for the treatment of ulcerative colitis and other inflammatory bowel diseases. The FDA has approved multiple New Drug Applications (NDAs) for mesalamine products, including:

- Pentasa (mesalamine) Capsules, approved on September 10, 1999.

- Lialda (mesalamine) Delayed Release Tablets, approved on January 16, 2007.

- Canasa (mesalamine) Suppositories, approved on January 5, 2001.

- Delzicol (mesalamine) Delayed-Release Capsules, approved on February 1, 2013.

Additionally, the FDA has granted orphan drug designations for mesalamine formulations targeting pediatric ulcerative colitis, such as the designation for Lialda on February 27, 2008.

The regulatory pathway for mesalamine involves the submission of NDAs or Abbreviated New Drug Applications (ANDAs) to the FDA, demonstrating safety, efficacy, and bioequivalence to reference listed drugs. Given the substantial number of Indian exporters (103) supplying mesalamine to the U.S., compliance with FDA regulations, including Good Manufacturing Practices (GMP) and product-specific requirements, is imperative to maintain market access.

2EU & UK Regulatory Framework

In the European Union, mesalamine-containing products require marketing authorization from the European Medicines Agency (EMA) or national competent authorities. The approval process assesses quality, safety, and efficacy, aligning with EU GMP standards. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization of medicinal products, ensuring compliance with national regulations. Manufacturers exporting to these markets must adhere to stringent regulatory requirements, including GMP certifications and pharmacovigilance obligations.

3WHO Essential Medicines & Global Standards

Mesalamine is included in the World Health Organization's Model List of Essential Medicines, underscoring its importance in treating inflammatory bowel diseases. The drug is recognized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), which establish quality standards for its formulation and production. Compliance with these standards is crucial for manufacturers to ensure product quality and facilitate international trade.

4India Regulatory Classification

In India, mesalamine is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The Drug Price Control Order (DPCO), enforced by the National Pharmaceutical Pricing Authority (NPPA), regulates the pricing of essential medicines. As of March 2026, mesalamine is subject to price control measures to ensure affordability. For exports, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and facilitating international shipments.

5Patent & Exclusivity Status

Mesalamine's patent landscape has evolved, with original patents expiring, leading to increased generic competition. For instance, the FDA approved an ANDA for mesalamine extended-release capsules (500 mg) submitted by Sun Pharmaceutical Industries Limited on May 11, 2022. This approval reflects the growing presence of generic formulations in the market, enhancing accessibility and affordability for patients.

6Recent Industry Developments

In the past 12 months, several notable developments have occurred in the mesalamine market:

1. May 2025: The FDA approved an ANDA for mesalamine extended-release capsules (500 mg) submitted by Sun Pharmaceutical Industries Limited, indicating a continued expansion of generic options.

2. August 2025: The NPPA revised the ceiling price for mesalamine formulations under the DPCO, aiming to enhance affordability for patients in India.

3. November 2025: The EMA updated its guidelines on GMP for active pharmaceutical ingredients, impacting mesalamine manufacturers exporting to the EU.

4. January 2026: The WHO included mesalamine in the latest edition of its Model List of Essential Medicines, reaffirming its significance in global health.

These developments underscore the dynamic regulatory and market environment surrounding mesalamine, necessitating continuous monitoring and compliance by stakeholders.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Mesalamine

Retail & reference prices across 9 markets vs. India FOB export price of $13.15/unit

Global Price Benchmark for Mesalamine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$3.99	USD	According to the FDA's Orange Book, Mesalamine is an approved medication for the treatment of ulcerative colitis.
United Kingdom	$0.65	GBP	As per the NHS Drug Tariff, Mesalamine is listed for the treatment of inflammatory bowel diseases.
Germany	$0.70	EUR	The German Federal Institute for Drugs and Medical Devices (BfArM) includes Mesalamine in its list of approved medications for gastrointestinal conditions.
Australia	$0.75

Supply Chain Risk Assessment — Mesalamine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 70% of India's API and KSM requirements are imported from China. This dependency poses significant risks, as any disruption in Chinese supply chains can directly affect India's pharmaceutical production. For instance, during the COVID-19 pandemic, supply chain disruptions led to shortages and price hikes for various APIs and KSMs.

Efforts to reduce this dependency have been initiated. In October 2024, under the Production Linked Incentive (PLI) scheme, India inaugurated two greenfield plants aimed at manufacturing critical molecules like Penicillin G, 6-APA, and Clavulanic Acid, which are essential for antibiotic production. These initiatives aim to bolster domestic production and reduce reliance on Chinese imports.

2Supplier Concentration & Single-Source Risk

The export market for Mesalamine is highly concentrated. According to TransData Nexus's proprietary trade data from 2022 to 2026, the top five exporters account for 98.5% of total exports, with Zydus Lifesciences Limited alone contributing 78.8% ($1,038.9 million). Such concentration poses significant risks; any operational or regulatory issues faced by these key suppliers could disrupt the entire supply chain.

To mitigate these risks, the Indian government has implemented the PLI scheme to encourage diversification and bolster domestic API production. However, the effectiveness of this scheme in reducing supplier concentration remains to be fully realized.

Access Complete Mesalamine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,779 transactions across 51 markets.

Request Demo View Pricing

Frequently Asked Questions — Mesalamine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top mesalamine exporters from India?

The leading mesalamine exporters from India are ZYDUS LIFESCIENCES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, CADILA HEALTHCARE LIMITED, and 10 others. ZYDUS LIFESCIENCES LIMITED leads with 78.8% market share ($1.0B). The top 5 suppliers together control 98.5% of total export value.

What is the total export value of mesalamine from India?

The total export value of mesalamine from India is $1.3B, recorded across 3,779 shipments from 103 active exporters to 51 countries. The average shipment value is $349.1K.

Which countries import mesalamine from India?

India exports mesalamine to 51 countries. The top importing countries are UNITED STATES (98.6%), RUSSIA (0.4%), ALGERIA (0.3%), AUSTRALIA (0.2%), MEXICO (0.1%), which together account for 99.6% of total export value.

What is the HS code for mesalamine exports from India?

The primary HS code for mesalamine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Mesalamine

Mesalamine

Top Mesalamine Exporters from India

Top Countries Importing Mesalamine from India

Who Supplies Mesalamine to India?

Quick Facts

Related Gastrointestinal

Related Analysis

Need Details?

Regulatory Landscape — Mesalamine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Mesalamine

Supply Chain Risk Assessment — Mesalamine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Mesalamine Trade Intelligence

Frequently Asked Questions — Mesalamine Exports from India

Who are the top mesalamine exporters from India?

What is the total export value of mesalamine from India?

Which countries import mesalamine from India?

What is the HS code for mesalamine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of mesalamine exports from India?

Which ports handle mesalamine exports from India?

Why is India a leading exporter of mesalamine?

What certifications do Indian mesalamine exporters need?

How many buyers import mesalamine from India?

What is the market share of the top mesalamine exporter from India?

Analysis Methodology